Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
HZNP
|
Timothy P Walbert
Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 26,353 Reduced 22.94% |
$337,318
$12.8 p/Share
|
Jan 02
2015 |
|
HZNP
|
Timothy P Walbert
Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 81,675 Added 41.55% |
-
|
Jan 02
2015 |
|
HZNP
|
Jeffrey W Sherman
EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,753 Reduced 7.88% |
$112,038
$12.8 p/Share
|
Jan 02
2015 |
|
HZNP
|
Jeffrey W Sherman
EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 26,750 Added 19.41% |
-
|
Jan 02
2015 |
|
R
|
Robert Hagemann
Director |
BUY
Grant, award, or other acquisition
|
Direct | 704 Added 36.29% |
$64,965
$92.28 p/Share
|
Jan 02
2015 |
|
NCLH
|
John Chidsey
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,605 Added 16.22% |
-
|
Jan 02
2015 |
|
NCLH
|
Walter L Revell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,140 Added 14.45% |
-
|
Jan 02
2015 |
|
NCLH
|
F Robert Salerno
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,070 Added 14.05% |
-
|
Jan 02
2015 |
|
FDX
|
Frederick W Smith
Executive Chairman |
SELL
Bona fide gift
|
Direct | 119,947 Reduced 0.78% |
-
|
Jan 02
2015 |
|
CVS
|
Per Gh Lofberg
EVP |
SELL
Open market or private sale
|
Direct | 347,343 Reduced 93.68% |
$33,094,841
$95.28 p/Share
|
Jan 02
2015 |
|
CVS
|
Per Gh Lofberg
EVP |
BUY
Exercise of conversion of derivative security
|
Direct | 347,343 Added 48.37% |
$15,654,749
$45.07 p/Share
|
Jan 02
2015 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 50,240 Reduced 54.91% |
$4,808,470
$95.71 p/Share
|
Jan 02
2015 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 50,240 Added 35.45% |
$1,756,390
$34.96 p/Share
|
Jan 02
2015 |
|
CVS
|
Andrew Sussman
EVP, Clinical Services |
SELL
Open market or private sale
|
Direct | 4,220 Reduced 59.97% |
$403,727
$95.67 p/Share
|
Jan 02
2015 |
|
ADBE
|
Shantanu Narayen
Chair and CEO |
SELL
Open market or private sale
|
Indirect | 36,762 Reduced 12.42% |
$2,683,994
$73.01 p/Share
|
Jan 02
2015 |
|
ADBE
|
Shantanu Narayen
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect | 36,762 Added 11.05% |
$1,255,790
$34.16 p/Share
|
Jan 02
2015 |
|
ORCL
|
Mark V Hurd
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 375,000 Reduced 99.73% |
$16,713,750
$44.57 p/Share
|
Jan 02
2015 |
|
ORCL
|
Mark V Hurd
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 375,000 Added 49.93% |
$9,052,500
$24.14 p/Share
|
Jan 02
2015 |
|
LGF-B
|
Wayne Levin
General Counsel and CSO |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 10.17% |
$395,375
$31.63 p/Share
|
Jan 02
2015 |
|
INTU
|
Edward A Kangas
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 11,500 Added 42.06% |
$297,850
$25.9 p/Share
|
Jan 02
2015 |
|
INTU
|
Edward A Kangas
Director |
SELL
Open market or private sale
|
Direct | 11,500 Reduced 72.6% |
$1,055,585
$91.79 p/Share
|
Jan 02
2015 |
|
IDCC
|
Lawrence F Shay
SEVP,Fut.Wireless,&Ch.IPCouns. |
SELL
Open market or private sale
|
Direct | 7,036 Reduced 12.49% |
$369,601
$52.53 p/Share
|
Jan 02
2015 |
|
SPOK
|
Nathaniel Blair Butterfield
Director |
BUY
Grant, award, or other acquisition
|
Direct | 864 Added 13.24% |
$14,999
$17.36 p/Share
|
Jan 02
2015 |
|
SPOK
|
Nicholas A Gallopo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,008 Added 3.05% |
$17,499
$17.36 p/Share
|
Jan 02
2015 |
|
SPOK
|
Brian Oreilly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 864 Added 4.81% |
$14,999
$17.36 p/Share
|
Jan 02
2015 |
|
SPOK
|
Matthew Oristano
Director |
BUY
Grant, award, or other acquisition
|
Direct | 864 Added 4.73% |
$14,999
$17.36 p/Share
|
Jan 02
2015 |
|
SPOK
|
Samme L Thompson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 864 Added 3.08% |
$14,999
$17.36 p/Share
|
Jan 02
2015 |
|
SPOK
|
Royce Yudkoff
Director |
BUY
Grant, award, or other acquisition
|
Direct | 864 Added 2.97% |
$14,999
$17.36 p/Share
|
Jan 02
2015 |
|
INTU
|
Edward A Kangas
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,341 Added 50.0% |
-
|
Jan 01
2015 |
|
PLXS
|
Stephen P Cortinovis
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,257 Added 20.99% |
-
|
Jan 01
2015 |
|
PLXS
|
Mary A Winston
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 15.89% |
-
|
Jan 01
2015 |
|
SPOK
|
Gary Ash
Global VP of Sales |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Colin Balmforth
President of USA Mobility Wire |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Danielle Brogan
Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Sean Collins
SVP of Sales |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Bonnie Culp Fingerhut
Ex. VP, HR & Adminstration |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Shawn Eric Endsley
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Hemant Goel
President of Spok, Inc. |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Vincent D Kelly
President & CEO |
BUY
Grant, award, or other acquisition
|
Indirect | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Tom Saine
Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
SPOK
|
Sharon Woods Keisling
Corporate Secretary, Treasurer |
BUY
Grant, award, or other acquisition
|
Direct | 0 Added 0.0% |
-
|
Jan 01
2015 |
|
IRDM
|
Thomas Fitzpatrick |
SELL
Payment of exercise price or tax liability
|
Direct | 3,572 Reduced 5.11% |
$34,827
$9.75 p/Share
|
Jan 01
2015 |
|
IRDM
|
S. Scott Smith
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 3,775 Reduced 6.36% |
$36,806
$9.75 p/Share
|
Jan 01
2015 |
|
IDCC
|
Richard Brezski
Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 0 Reduced 0.0% |
$0
$52.9 p/Share
|
Jan 01
2015 |
|
IDCC
|
Richard Brezski
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,966 Reduced 8.11% |
$104,001
$52.9 p/Share
|
Jan 01
2015 |
|
IDCC
|
Richard Brezski
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,968 Added 14.76% |
-
|
Jan 01
2015 |
|
IDCC
|
Scott A Mc Quilkin
Sr. EVP, Innovation |
SELL
Sale (or disposition) back to the issuer
|
Direct | 0 Reduced 0.0% |
$0
$52.9 p/Share
|
Jan 01
2015 |
|
IDCC
|
Scott A Mc Quilkin
Sr. EVP, Innovation |
SELL
Payment of exercise price or tax liability
|
Direct | 2,893 Reduced 4.96% |
$153,040
$52.9 p/Share
|
Jan 01
2015 |
|
IDCC
|
Scott A Mc Quilkin
Sr. EVP, Innovation |
BUY
Grant, award, or other acquisition
|
Direct | 6,356 Added 9.95% |
-
|
Jan 01
2015 |
|
IDCC
|
William J Merritt
President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 0 Reduced 0.0% |
$0
$52.9 p/Share
|
Jan 01
2015 |